5 Game-Changing Cancer Drug Innovations Being Developed Right Now
Image source: Getty Images.
"The emperor of all maladies, the king of terrors." This phrase was used by a 19th century surgeon to describe cancer. More than a century later, the description unfortunately still applies. Oncologist Siddhartha Mukherjee even used the first part of the phrase as the title for his best-selling book about cancer.
Many scientists in both the public and private sector, however, are hard at work attempting to dethrone this terrible emperor. Significant advances have been made in recent years, some of which are now becoming available to cancer patients, with others hopefully only a few years away. Here are five potentially game-changing cancer-drug innovations that are being developed right now.
Source: Fool.com
Merck & Co. Inc. Stock
€118.80
-1.820%
The stock is one of the favorites of our community with 30 Buy predictions and 1 Sell predictions.
As a result the target price of 124 € shows a slightly positive potential of 4.38% compared to the current price of 118.8 € for Merck & Co. Inc..
